Isis Pharmaceuticals Prices Offering of $425M Of 1.00% Convertible Senior Notes
November 12, 2014 at 07:02 AM EST
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today the pricing of its offering of $425.0 million aggregate principal amount of ...